Literature DB >> 27027249

Sex-specific mediation effect of the right fusiform face area volume on the association between variants in repeat length of AVPR1A RS3 and altruistic behavior in healthy adults.

Junping Wang1, Wen Qin1, Feng Liu1, Bing Liu2,3, Yuan Zhou4, Tianzi Jiang2,3, Chunshui Yu1.   

Abstract

Microsatellite variants in the arginine vasopressin receptor 1A gene (AVPR1A) RS3 have been associated with normal social behaviors variation and autism spectrum disorders (ASDs) in a sex-specific manner. However, neural mechanisms underlying these associations remain largely unknown. We hypothesized that AVPR1A RS3 variants affect altruistic behavior by modulating the gray matter volume (GMV) of specific brain regions in a sex-specific manner. We investigated 278 young healthy adults using the Dictator Game to assess altruistic behavior. All subjects were genotyped and main effect of AVPR1A RS3 repeat polymorphisms and interaction of genotype-by-sex on the GMV were assessed in a voxel-wise manner. We observed that male subjects with relatively short repeats allocated less money to others and exhibited a significantly smaller GMV in the right fusiform face area (FFA) compared with male long homozygotes. In male subjects, the GMV of the right FFA exhibited a significant positive correlation with altruistic behavior. A mixed mediation and moderation analysis further revealed both a significant mediation effect of the GMV of the right FFA on the association between AVPR1A RS3 repeat polymorphisms and allocation sums and a significant moderation effect of sex (only in males) on the mediation effect. Post hoc analysis showed that the GMV of the right FFA was significantly smaller in male subjects carrying allele 426 than in non-426 carriers. These results suggest that the GMV of the right FFA may be a potential mediator whereby the genetic variants in AVPR1A RS3 affect altruistic behavior in healthy male subjects. Hum Brain Mapp 37:2700-2709, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  arginine vasopressin receptor 1A; autism spectrum disorder; fusiform face area; gray matter volume; mediation analysis; microsatellite

Mesh:

Substances:

Year:  2016        PMID: 27027249      PMCID: PMC6867363          DOI: 10.1002/hbm.23203

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  45 in total

Review 1.  The neurobiology of pair bonding.

Authors:  Larry J Young; Zuoxin Wang
Journal:  Nat Neurosci       Date:  2004-10       Impact factor: 24.884

2.  Arginine vasopressin 1a receptor gene and maternal behavior: evidence of association and moderation.

Authors:  R Bisceglia; J M Jenkins; K G Wigg; T G O'Connor; G Moran; C L Barr
Journal:  Genes Brain Behav       Date:  2012-03-01       Impact factor: 3.449

Review 3.  Prosocial behavior: multilevel perspectives.

Authors:  Louis A Penner; John F Dovidio; Jane A Piliavin; David A Schroeder
Journal:  Annu Rev Psychol       Date:  2005       Impact factor: 24.137

4.  Microsatellite instability generates diversity in brain and sociobehavioral traits.

Authors:  Elizabeth A D Hammock; Larry J Young
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

5.  Sex-specific influences of vasopressin on human social communication.

Authors:  R R Thompson; K George; J C Walton; S P Orr; J Benson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 6.  Neuropeptidergic regulation of affiliative behavior and social bonding in animals.

Authors:  Miranda M Lim; Larry J Young
Journal:  Horm Behav       Date:  2006-08-04       Impact factor: 3.587

7.  Pervasive developmental disorders in preschool children: confirmation of high prevalence.

Authors:  Suniti Chakrabarti; Eric Fombonne
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

8.  Clinical and anatomical heterogeneity in autistic spectrum disorder: a structural MRI study.

Authors:  F Toal; E M Daly; L Page; Q Deeley; B Hallahan; O Bloemen; W J Cutter; M J Brammer; S Curran; D Robertson; C Murphy; K C Murphy; D G M Murphy
Journal:  Psychol Med       Date:  2009-11-06       Impact factor: 7.723

9.  Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills.

Authors:  N Yirmiya; C Rosenberg; S Levi; S Salomon; C Shulman; L Nemanov; C Dina; R P Ebstein
Journal:  Mol Psychiatry       Date:  2006-05       Impact factor: 15.992

10.  Brain responses to the acquired moral status of faces.

Authors:  Tania Singer; Stefan J Kiebel; Joel S Winston; Raymond J Dolan; Chris D Frith
Journal:  Neuron       Date:  2004-02-19       Impact factor: 17.173

View more
  5 in total

1.  ASD and Genetic Associations with Receptors for Oxytocin and Vasopressin-AVPR1A, AVPR1B, and OXTR.

Authors:  Sunday M Francis; Soo-Jeong Kim; Emily Kistner-Griffin; Stephen Guter; Edwin H Cook; Suma Jacob
Journal:  Front Neurosci       Date:  2016-11-22       Impact factor: 4.677

Review 2.  Functional Mechanisms of Microsatellite DNA in Eukaryotic Genomes.

Authors:  Andrew T M Bagshaw
Journal:  Genome Biol Evol       Date:  2017-09-01       Impact factor: 3.416

3.  No association between genetic variants in MAOA, OXTR, and AVPR1a and cooperative strategies.

Authors:  María I Rivera-Hechem; Carlos Rodríguez-Sickert; Ricardo A Guzmán; Tadeo Ramírez-Parada; Felipe Benavides; Víctor Landaeta-Torres; Mauricio Aspé-Sánchez; Gabriela M Repetto
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

4.  Dose-Dependent and Lasting Influences of Intranasal Vasopressin on Face Processing in Men.

Authors:  Daniel Price; Debra Burris; Anna Cloutier; Carol B Thompson; James K Rilling; Richmond R Thompson
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-22       Impact factor: 5.555

Review 5.  A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder.

Authors:  Ilaria Cataldo; Atiqah Azhari; Gianluca Esposito
Journal:  Front Mol Neurosci       Date:  2018-02-13       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.